Viva BioInnovator

Viva BioInnovator

Shanghai, Shanghaivivabiotech.com

Overview

Viva BioInnovator is dedicated to investing globally in biotech innovation with novel solutions to unmet medical needs across multiple therapeutic areas ranging from biopharmaceuticals to devices, diagnostics, and life science tools. By leveraging Viva Biotech's rich experience and technical advantages in novel drug R&D, we provide both cash and in-kind services, also called Equity-for-Services (EFS), for our investments. We can also work with start-ups through our incubation track which offers value-added services in operations, logistical support, and more to support early-stage development.

Year Founded

2014

Portfolio Companies

18

Investments

CompanyDateStageLead
Kainova TherapeuticsFeb 2026Series BCo-investor
TechnoDerma Medicines Inc.Jan 2024Early FundingCo-investor
ReglageneDec 2023Series ACo-investor
TechnoDerma Medicines Inc.Jan 2023Series A ExtensionCo-investor
Domain TherapeuticsMay 2022Series ACo-investor

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersShanghai, Shanghai
Year Founded2014

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.